Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies
Lorgeot, V.; Praloran, V.; Turlure, P.; Denizot, Y.
Leukemia 11(2): 311-312
1997
ISSN/ISBN: 0887-6924 PMID: 9009099 Document Number: 478883
Document emailed within 1 workday
Related Documents
Usui, N. 2017: Hematologic Malignancies/Pediatric Malignancies Acute Leukemia - Current Treatment and Future Perspective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(5): 378-379Usui, N. 2011: Hematologic malignancies/ pediatric malignancies-chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 744
Usui, N. 2019: Hematologic Malignancies/Pediatric Malignancies Current Guidelines of Clinical Management and Drug Therapy for Hematological Malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 859-861
Tallman, M.S. 1994: All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies Seminars in Hematology 31(4 Suppl 5: 38-48
Ratajczak, J.; Machaliński, B.; Marlicz, W.; Hałasa, M.; Ratajczak, M.Z. 1997: Influence of leukemia inhibitory factor (LIF) on the survival, proliferation and differentiation of human erythroid progenitor cells. In vitro studies under serum free conditions Folia Histochemica et Cytobiologica 35(2): 63-68
Powers, T.E.; Varma, K.J.; Powers, J.D. 1984: Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations Journal of the American Veterinary Medical Association 185(10): 1062-1067
Miyahara, T.; Torisu, M. 1981: Serum inhibitory factor for guinea pig macrophage and neutrophil chemotaxis found in cancer patients Gan 72(6): 854-861
Kozaci, L.D.; Sari, I.; Akar, S.; Bırlık, M.; Akkoç, N.; Chikanza, I.C.; Onen, F.ş 2010: Serum levels of macrophage migration inhibitory factor and leptin in patients with acute trichinellosis Turkiye Parazitolojii Dergisi 34(3): 156-160
Laprée-Delage, G.; Moreau, J.F.; Taupin, J.L.; Kadhel, P.; Olivennes, F.; Hambartsoumian, E.; Frydman, R.; Tartakovsky, B.; Chaouat, G. 1997: Abnormal endometrial reactivity to colony stimulating factor 1 and leukemia inhibitory factor dependent female infertility Contraception Fertilite Sexualite 25(9): 711-716
Murakami, H.; Saitoh, T.; Kasamatsu, T. 2016: Hematologic Malignancies/Pediatric Malignancies. III. Treatment of Relapsed/Refractory Multiple Myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(5): 539-544
Vyzantiadis, T.; Theodoridou, S.; Giouleme, O.; Harsoulis, P.; Evgenidis, N.; Vyzantiadis, A. 2003: Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis Hepato-Gastroenterology 50(51): 814-816
Hernández, J.A.; Martino, R.; Pericas, R.; Sureda, A.; Brunet, S.; Domingo-Albós, A. 1998: Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies Haematologica 83(3): 284-285
deMagalhaes-Silverman, M.; Bloom, E.J.; Donnenberg, A.; Lister, J.; Pincus, S.; Rybka, W.B.; Ball, E.D. 1996: Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies Bone Marrow Transplantation 17(3): 329-333
Honma, Y. 2005: LIF (leukemia inhibitory factor) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 123-124
Fleit, H.B.; Kobasiuk, C.D. 1993: Soluble Fc gamma RIII is present in lower concentrations in the serum of patients with acute myelogenous leukemia (AML): a retrospective study Leukemia 7(8): 1250-1252
Chen, J.; Wen, A.; Hong, D. 2000: Changes and significance of concentrations of serum vascular endothelial growth factor in patients with pregnancy induced hypertension Zhonghua Fu Chan Ke Za Zhi 35(2): 72-74
Niscola, P.; de Fabritiis, P.; Cartoni, C.; Romani, C.; Sorrentino, F.; Dentamaro, T.; Piccioni, D.; Scaramucci, L.; Giovannini, M.; Amadori, S.; Mandelli, F. 2006: Home care management of patients affected by hematologic malignancies: a review Haematologica 91(11): 1523-1529
Nenova, I.S.; Goranov, S.E.; Mateva, N.G.; Ananoshtev, N.H. 2003: Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies Folia Medica 45(1): 13-19
Laban-Guceva, N.; Bogoev, M.; Antova, M. 2007: Serum concentrations of interleukin (IL-)1alpha, 1beta, 6 and tumor necrosis factor (TNF-) alpha in patients with thyroid eye disease (TED) Medicinski Arhiv 61(4): 203-206
Kasukabe, T.; Okabe-Kado, J.; Hozumi, M.; Honma, Y. 1994: Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes Cancer Research 54(2): 592-597